mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats - PubMed (original) (raw)
mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats
Olga A Dravolina et al. Neuropharmacology. 2007 Feb.
Abstract
Glutamatergic neurotransmission is believed to be critically involved in the acquisition and maintenance of drug addiction. The present study evaluated the role of metabotropic glutamate (mGlu) 1 receptors in the reinstatement of nicotine-seeking behavior. Rats were trained to nose-poke to receive response-contingent intravenous infusions of nicotine (0.01 mg/kg/infusion, free base). Following the subsequent extinction phase, reinstatement tests were conducted in animals that were exposed either to response-contingent presentations of the nicotine-associated discrete light cues or to non-contingent nicotine priming injection (0.3mg/kg, s.c., salt) just prior to the test session. In a separate experiment, rats were subjected to the nearly identical response-reinstatement procedure but operant responding was established using food pellets instead of nicotine infusions. Pretreatment with the mGlu1 receptor antagonist EMQMCM (JNJ16567083, (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate) significantly inhibited cue-induced reinstatement of nicotine-seeking behavior (5 and 10, but not 2.5 mg/kg). EMQMCM (5 mg/kg) also prevented nicotine priming-induced reinstatement of nicotine-seeking behavior. At the highest tested dose only (10 mg/kg), EMQMCM attenuated cue-induced reinstatement of food-seeking behavior. Taken together with the previous reports, the present findings further suggest that blockade of mGlu1 receptors may be beneficial for preventing relapse to tobacco smoking in nicotine-dependent individuals.
Similar articles
- Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
Bespalov AY, Dravolina OA, Sukhanov I, Zakharova E, Blokhina E, Zvartau E, Danysz W, van Heeke G, Markou A. Bespalov AY, et al. Neuropharmacology. 2005;49 Suppl 1:167-78. doi: 10.1016/j.neuropharm.2005.06.007. Neuropharmacology. 2005. PMID: 16023685 - Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
Uslaner JM, Drott JT, Sharik SS, Theberge CR, Sur C, Zeng Z, Williams DL, Hutson PH. Uslaner JM, et al. Behav Brain Res. 2010 Feb 11;207(1):37-43. doi: 10.1016/j.bbr.2009.09.035. Epub 2009 Sep 30. Behav Brain Res. 2010. PMID: 19799936 - SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM, Lange JH, Kruse CG, Herremans AH, Schoffelmeer AN, van Drimmelen M, De Vries TJ. de Bruin NM, et al. Behav Brain Res. 2011 Mar 1;217(2):408-15. doi: 10.1016/j.bbr.2010.11.013. Epub 2010 Nov 11. Behav Brain Res. 2011. PMID: 21074574 - Neural substrates of cocaine-cue associations that trigger relapse.
See RE. See RE. Eur J Pharmacol. 2005 Dec 5;526(1-3):140-6. doi: 10.1016/j.ejphar.2005.09.034. Epub 2005 Oct 25. Eur J Pharmacol. 2005. PMID: 16253228 Review. - Cue dependency of nicotine self-administration and smoking.
Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF. Caggiula AR, et al. Pharmacol Biochem Behav. 2001 Dec;70(4):515-30. doi: 10.1016/s0091-3057(01)00676-1. Pharmacol Biochem Behav. 2001. PMID: 11796151 Review.
Cited by
- mGlu receptors and drug addiction.
Cleva RM, Olive MF. Cleva RM, et al. Wiley Interdiscip Rev Membr Transp Signal. 2012 May;1(3):281-295. doi: 10.1002/wmts.18. Epub 2012 Jan 20. Wiley Interdiscip Rev Membr Transp Signal. 2012. PMID: 22662312 Free PMC article. - Substance abuse and neurotransmission.
Davis S, Zhu J. Davis S, et al. Adv Pharmacol. 2022;93:403-441. doi: 10.1016/bs.apha.2021.10.007. Epub 2022 Jan 17. Adv Pharmacol. 2022. PMID: 35341573 Free PMC article. - Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
Luessen DJ, Conn PJ. Luessen DJ, et al. Pharmacol Rev. 2022 Jul;74(3):630-661. doi: 10.1124/pharmrev.121.000540. Pharmacol Rev. 2022. PMID: 35710132 Free PMC article. Review. - Role of cues and contexts on drug-seeking behaviour.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Perry CJ, et al. Br J Pharmacol. 2014 Oct;171(20):4636-72. doi: 10.1111/bph.12735. Epub 2014 Jul 2. Br J Pharmacol. 2014. PMID: 24749941 Free PMC article. Review. - mGluR5 is necessary for maintenance of methamphetamine-induced associative learning.
Herrold AA, Voigt RM, Napier TC. Herrold AA, et al. Eur Neuropsychopharmacol. 2013 Jul;23(7):691-6. doi: 10.1016/j.euroneuro.2012.05.014. Epub 2012 Jun 23. Eur Neuropsychopharmacol. 2013. PMID: 22732517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources